Acumen Pharmaceuticals (ABOS) Leases (2022 - 2026)
Acumen Pharmaceuticals recorded quarterly Leases of $106000.0 in Q1 2026, down 24.29% quarter-over-quarter from $140000.0 in Q4 2025, and down 55.08% year-over-year from $236000.0 in Q1 2025.
Acumen Pharmaceuticals' Leases history runs 5 years deep, the most recent figure standing at $106000.0 for Q1 2026.
- In Q1 2026, Leases fell 55.08% year-over-year to $106000.0; the TTM figure through Mar 2026 stood at $106000.0 (down 55.08% YoY), while the FY2025 annual figure was $140000.0, down 47.37% from the prior year.
- Leases came in at $106000.0 for Q1 2026 at Acumen Pharmaceuticals, down from $140000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $381000.0 in Q4 2023 to a low of $2000.0 in Q3 2023.
- A 5-year average of $187352.9 and a median of $173000.0 in 2025 frame the typical range for Leases.
- Across the five-year window, Leases tumbled 98.5% in 2023 and jumped 14700.0% in 2024, its largest moves.
- Acumen Pharmaceuticals' Leases stood at $105000.0 in 2022, then surged by 262.86% to $381000.0 in 2023, then slumped by 30.18% to $266000.0 in 2024, then sank by 47.37% to $140000.0 in 2025, then retreated by 24.29% to $106000.0 in 2026.
- According to Business Quant data, Leases over the past three periods registered $106000.0, $140000.0, and $173000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 173,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 266,000.00 |
| Sep 30, 2024 | 296,000.00 |
| Jun 30, 2024 | 325,000.00 |
| Mar 31, 2024 | 353,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2022 | 201,000.00 |